Page last updated: 2024-10-22

ag-1296 and Mastocytosis

ag-1296 has been researched along with Mastocytosis in 1 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Letard, S1
Yang, Y1
Hanssens, K1
Palmérini, F1
Leventhal, PS1
Guéry, S1
Moussy, A1
Kinet, JP1
Hermine, O1
Dubreuil, P1

Other Studies

1 other study available for ag-1296 and Mastocytosis

ArticleYear
Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors.
    Molecular cancer research : MCR, 2008, Volume: 6, Issue:7

    Topics: Animals; Cell Line; Cell Proliferation; Dogs; Extracellular Space; Female; Flow Cytometry; Intercell

2008